ampelopsin has been researched along with Insulin Sensitivity in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 8 (80.00) | 24.3611 |
| 2020's | 2 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, L; Mi, M; Qin, Y; Wan, J; Wu, Y; Zhang, Q; Zhou, Y; Zhu, J; Zou, L | 1 |
| Cai, G; Hou, L; Hu, CY; Huang, B; Jiang, F; Jiang, Y; Liu, D; Wang, C; Zheng, W | 1 |
| Hou, P; Mi, M; Yao, Y; Yi, L; Yue, J; Zhang, Q; Zhou, J | 1 |
| Chen, K; Gong, X; Gu, Y; Lang, H; Mi, M; Ran, L; Wang, X; Zhou, M; Zhou, Q; Zhu, J | 1 |
| Lang, H; Liu, L; Mi, M; Zhou, M; Zhou, Y | 1 |
| Chen, M; Hu, Q; Huang, J; Liang, X; Mi, M; Shi, L; Zhang, Q; Zhang, T; Zhou, Y; Zhu, J | 1 |
| Mi, M; Ran, L; Shi, L; Zeng, X; Zhang, Q; Zhang, T; Zhou, Y; Zhu, J | 1 |
| Chen, S; Gao, Y; Liu, P; Mi, M; Qin, Y; Ran, L; Shu, F; Wan, J; Wang, X; Zhang, Q; Zhang, Y; Zhao, X; Zhu, J | 1 |
| Hu, K; Jiang, B; Le, L; Wan, W; Xiao, P; Xu, L; Zhai, W | 1 |
| Lang, H; Liu, L; Mi, M; Si, M; Wan, J; Zhou, Y; Zhu, J | 1 |
1 trial(s) available for ampelopsin and Insulin Sensitivity
| Article | Year |
|---|---|
Dihydromyricetin improves glucose and lipid metabolism and exerts anti-inflammatory effects in nonalcoholic fatty liver disease: A randomized controlled trial.
Topics: Adult; Ampelopsis; Biomarkers; Double-Blind Method; Female; Flavonols; Glucose; Humans; Insulin Resistance; Lipid Metabolism; Male; Middle Aged; Non-alcoholic Fatty Liver Disease; Plants, Medicinal | 2015 |
9 other study(ies) available for ampelopsin and Insulin Sensitivity
| Article | Year |
|---|---|
Ampelopsin Improves Insulin Resistance by Activating PPARγ and Subsequently Up-Regulating FGF21-AMPK Signaling Pathway.
Topics: AMP-Activated Protein Kinases; Anilides; Animals; Blotting, Western; Cell Line; Fibroblast Growth Factors; Flavonoids; Glucose; Insulin Resistance; Muscle Fibers, Skeletal; PPAR gamma; Rats; RNA Interference; RNA, Small Interfering; Signal Transduction | 2016 |
Dihydromyricetin Ameliorates Inflammation-Induced Insulin Resistance via Phospholipase C-CaMKK-AMPK Signal Pathway.
Topics: AMP-Activated Protein Kinases; Animals; Calcium-Calmodulin-Dependent Protein Kinase Kinase; Diabetes Mellitus, Type 2; Flavonols; Inflammation; Insulin Resistance; Male; Mice, Inbred C57BL; Signal Transduction | 2021 |
Dihydromyricetin Improves High-Fat Diet-Induced Hyperglycemia through ILC3 Activation via a SIRT3-Dependent Mechanism.
Topics: Animals; Diet, High-Fat; Flavonols; Hyperglycemia; Immunity, Innate; Insulin Resistance; Lymphocytes; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Sirtuin 3 | 2022 |
Dihydromyricetin prevents obesity-induced slow-twitch-fiber reduction partially via FLCN/FNIP1/AMPK pathway.
Topics: AMP-Activated Protein Kinases; Animals; Carrier Proteins; Dietary Fats; Flavonols; Gene Expression Regulation; Insulin Resistance; Male; Mice; Muscle Fibers, Slow-Twitch; Obesity; Proto-Oncogene Proteins; Signal Transduction; Tumor Suppressor Proteins | 2017 |
Dihydromyricetin enhances glucose uptake by inhibition of MEK/ERK pathway and consequent down-regulation of phosphorylation of PPARγ in 3T3-L1 cells.
Topics: 3T3-L1 Cells; Adipocytes; Adipogenesis; Adiponectin; Anilides; Animals; Cell Survival; Dexamethasone; Down-Regulation; Fibroblast Growth Factors; Flavonoids; Flavonols; Glucose; Insulin Resistance; MAP Kinase Signaling System; Mice; Mitogen-Activated Protein Kinase Kinases; Phosphorylation; Phosphoserine; PPAR gamma | 2018 |
Dihydromyricetin improves skeletal muscle insulin resistance by inducing autophagy via the AMPK signaling pathway.
Topics: Adenine; AMP-Activated Protein Kinases; Animals; Autophagy; Cells, Cultured; Diabetes Mellitus, Type 2; Diet, High-Fat; Flavonols; Gene Expression Regulation; Insulin Resistance; Macrolides; Male; Muscle, Skeletal; Phosphorylation; Rats; Rats, Sprague-Dawley; Signal Transduction | 2015 |
Dihydromyricetin improves skeletal muscle insulin sensitivity by inducing autophagy via the AMPK-PGC-1α-Sirt3 signaling pathway.
Topics: AMP-Activated Protein Kinases; Animals; Autophagy; Flavonols; Insulin Resistance; Male; Mice; Mice, 129 Strain; Muscle, Skeletal; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Signal Transduction; Sirtuin 3; Transcription Factors | 2015 |
Metabolomics reveals the protective of Dihydromyricetin on glucose homeostasis by enhancing insulin sensitivity.
Topics: AMP-Activated Protein Kinase Kinases; AMP-Activated Protein Kinases; Animals; Citric Acid Cycle; Diet, High-Fat; Flavonols; Glucose; Glycogen Synthase Kinase 3 beta; Hep G2 Cells; Humans; Hyperglycemia; Insulin; Insulin Receptor Substrate Proteins; Insulin Resistance; Liver; Male; Metabolic Networks and Pathways; Protective Agents; Protein Serine-Threonine Kinases; Rats; Rats, Sprague-Dawley; Signal Transduction; Up-Regulation | 2016 |
Dihydromyricetin delays the onset of hyperglycemia and ameliorates insulin resistance without excessive weight gain in Zucker diabetic fatty rats.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Disease Progression; Flavonols; Hyperglycemia; Insulin Resistance; Male; Obesity; Rats; Rats, Zucker; Time Factors; Weight Gain | 2017 |